白介素33(IL33)檢測試劑盒(化學(xué)發(fā)光免疫分析法)
CLIA Kit for Interleukin 33 (IL33)
DV27; C9ORF26; IL1F11; NFHEV; Interleukin-1 Family, Member 11; Nuclear factor from high endothelial venules
- 編號SCB980Hu
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 實驗方法雙抗夾心
- 反應(yīng)時長2h, 40min
- 檢測范圍1.37-1000pg/mL
- 靈敏度最小可檢測劑量小于等于0.55pg/mL.
- 樣本類型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說明書 中文說明書
- 規(guī)格 48T96T 96T*5 96T*10 96T*100
- 價格 ¥ 3528 ¥ 5040 ¥ 22680 ¥ 42840 ¥ 352800
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
本試劑盒用于檢測白介素33(IL33),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來源的限制,不可能完成對所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的白介素33(IL33)(加標(biāo)樣品),重復(fù)測定并計算其均值,回收率為測定值與理論值的比率。
樣本 | 回收率范圍(%) | 平均回收率(%) |
serum(n=5) | 79-105 | 102 |
EDTA plasma(n=5) | 85-104 | 95 |
heparin plasma(n=5) | 98-105 | 102 |
精密度
精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進(jìn)行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進(jìn)行定量測定,每個樣本使用同一試劑盒重復(fù)測定8次,分別計算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的白介素33(IL33),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中白介素33(IL33)含量的測定值與理論值的比率。
樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 92-101% | 90-104% | 88-101% | 80-104% |
EDTA plasma(n=5) | 88-95% | 84-101% | 88-101% | 78-105% |
heparin plasma(n=5) | 82-96% | 97-104% | 81-97% | 98-105% |
穩(wěn)定性
經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響,實驗室的環(huán)境條件需盡量保持一致,尤其是實驗室內(nèi)溫度、濕度及溫育條件。其次由同一實驗員來進(jìn)行操作可減少人為誤差。
實驗流程
1. 實驗前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備;
2. 加樣(標(biāo)準(zhǔn)品及樣本)100µL,37°C孵育1小時;
3. 吸棄,加檢測溶液A100μL,37°C孵育1小時;
4. 洗板3次;
5. 加檢測溶液B100µL,37°C孵育30分鐘;
6. 洗板5次;
7. 加底物100µL,37°C孵育10分鐘;
8. 讀數(shù)。
實驗原理
將白介素33(IL33)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本,其中的白介素33(IL33)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的白介素33(IL33)抗體,將未結(jié)合的生物素化抗體洗凈后,加入HRP標(biāo)記的親和素,再次徹底洗滌后加入底物。加入底物后會產(chǎn)生輝光型光信號。發(fā)射光強(qiáng)度和樣品中的白介素33(IL33)呈正相關(guān)。用化學(xué)發(fā)光儀測定相對光單位(RLU),計算樣品濃度。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB980Hu02 | 白介素33(IL33)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APB980Hu01 | 白介素33(IL33)活性蛋白 | Cell?culture;?Activity?Assays. |
RPB980Hu01 | 白介素33(IL33)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB980Hu02 | 白介素33(IL33)多克隆抗體 | WB; IHC; ICC; IP. |
PAB980Hu01 | 白介素33(IL33)多克隆抗體 | WB; IHC; ICC; IP. |
LAB980Hu71 | 白介素33(IL33)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
RAB980Hu21 | 白介素33(IL33)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
MAB980Hu24 | 白介素33(IL33)單克隆抗體 | WB; IHC; ICC; IP. |
MAB980Hu26 | 白介素33(IL33)單克隆抗體 | WB; IHC; ICC; IP. |
MAB980Hu21 | 白介素33(IL33)單克隆抗體 | WB; IHC; ICC; IP. |
MAB980Hu22 | 白介素33(IL33)單克隆抗體 | WB; IHC |
LAB980Hu72 | 白介素33(IL33)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
LAB980Hu76 | 白介素33(IL33)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
SEB980Hu | 白介素33(IL33)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCB980Hu | 白介素33(IL33)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMB980Hu | 白介素33(IL33)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
PSB980Hu01 | 白介素33(IL33)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSB980Hu01 | 白介素33(IL33)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
The Korean Journal of Internal Medicine | Interleukin-33, matrix metalloproteinase-9, and tissue ?nhibitor of matrix metalloproteinase-1 in myocardial infarction [PubMed: PMC3604606] |
Acta Histochem | CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice [PubMed: 26456520] |
Journal of Interferon & Cytokine Research | Epithelial Cell-Derived Cytokines Contribute to the Pathophysiology of Eosinophilic Chronic Rhinosinusitis [Pubmed:26540312] |
Journal of Interferon & Cytokine Research | The Expression and Regulation of Interleukin-33 in Human Epidermal Keratinocytes: A New Mediator of Atopic Dermatitis and Its Possible Signaling Pathway. [pubmed:27348082] |
Archives of Dermatological Research | IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo [pubmed:27388717] |
Sci Pharm. | Chrysin Protects?Rat?Kidney from Paracetamol-Induced Oxidative Stress, Inflammation, Apoptosis, and Autophagy: A Multi-Biomarker Approach. [pubmed:28134775] |
Biotechnology & Biotechnological Equipment? | Association of IL-33, IL1RL1 gene polymorphisms with serum IL-33 levels and risk of asthma in adults and asthmatic bronchitis in children (Chinese) [10.1080:13102818.2018.1471361] |
Tropical Journal of Pharmaceutical Research | Role of IL-33 and ST2 signaling and inflammatory responses in non-small cell lung cancer [172341] |
Particle and?Fibre?Toxicology | Group II innate lymphoid cells and microvascular dysfunction from pulmonary titanium dioxide nanoparticle exposure [Pubmed: 30413212] |
Scientific Reports | Interleukin-33 serum levels in postmenopausal women with osteoporosis [Pubmed: 30846811] |
Cell Reports | Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s [Pubmed: 32101749] |
Allergy Asthma & Immunology Research | Relationship of microbial profile with airway immune response in eosinophilic or neutrophilic inflammation of asthmatics [Pubmed: 32141256] |
Traditional Medicine Research | Qingfei oral liquid downregulates TRPV1 expression to reduce airway inflammation and mucus hypersecretion injury caused by respiratory syncytial virus infection … [] |
Aggravation of Airway Inflammation in RSV-Infected Asthmatic Mice Following Infection-Induced Alteration of Gut Microbiota [] | |
J Immunol Res | Inhibition of NF-κB/IL-33/ST2 Axis Ameliorates Acute Bronchiolitis Induced by Respiratory Syncytial Virus [34395633] |
Pathogens | Elevated Levels of IL-33, IL-17 and IL-25 Indicate the Progression from Chronicity to Hepatocellular Carcinoma in Hepatitis C Virus Patients [Pubmed:35056005] |
researchsquare | Dexmedetomidine Attenuates Hyperalgesia Induced By Brachial Plexus Root Avulsion By Restoring The GLT-1 Function Via PKA Signaling [] |